methylprednisolone has been researched along with calcitriol in 25 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 4 (16.00) | 18.7374 |
1990's | 6 (24.00) | 18.2507 |
2000's | 8 (32.00) | 29.6817 |
2010's | 4 (16.00) | 24.3611 |
2020's | 3 (12.00) | 2.80 |
Authors | Studies |
---|---|
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
Andricopulo, AD; Moda, TL; Montanari, CA | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Bijlsma, JW; van der Veen, MJ | 1 |
Egfjord, M; Olgaard, K; Staun, M | 1 |
Bijlsma, JW; Bosch, R; Duursma, SA; Huber-Bruning, O; Raymakers, JA | 1 |
Baldet, P; Blotman, F; Bonnel, F; Colette, C; Mirouze, J; Monnier, L | 1 |
Bijlsma, JW; Duursma, SA; Huber-Bruning, O | 1 |
Dreikorn, K; Krause, KH; Neubauer, E; Neubauer, N; Ritz, E | 1 |
Kasperk, C; Niethard, F; Schneider, U; Sommer, U; Ziegler, R | 1 |
Campistol, JM; Fenollosa, B; Martinez de Osaba, MJ; Montesinos, M; Oppenheimer, F; Pons, F; Torregrosa, JV | 1 |
Cosman, F; Herbert, J; Lindsay, R; Nieves, J; Shen, V | 1 |
Brown, G; Bunce, CM; Drayson, MT; Durham, J; Wallington, LA | 1 |
Fujigaki, Y; Hishida, A; Suzuki, H; Yonemura, K | 1 |
Antonello, A; Carraro, G; Crepaldi, G; D'Angelo, A; Di Landro, D; Giannini, S; Marchini, F; Plebani, M; Rigotti, P; Sartori, L; Zaninotto, M | 1 |
DiCarlo, JB; Gupta, EA; Solomon, AR | 1 |
Adişen, E; Dursun, A; Erdem, O; Gülekon, A; Gürer, MA | 1 |
Iwamoto, J; Sato, Y; Seki, A; Shen, CL; Takeda, T; Yamada, H; Yeh, JK | 1 |
Funatogawa, I; Funatogawa, T; Ohashi, Y | 1 |
Inayat, F; Khan, Z; Mohyudin, A; Saleem, S | 1 |
Jin, W; Lu, M; Yang, X | 1 |
Evangelopoulos, DS; Evangelopoulos, ME; Kassi, E; Moutsatsou, P; Nasiri-Ansari, N; Papadopoulou, A | 1 |
Grubczak, K; Krętowska, M; Makowska, B; Moniuszko, M; Naumnik, B; Parfienowicz, Z; Starosz, A | 1 |
1 review(s) available for methylprednisolone and calcitriol
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
4 trial(s) available for methylprednisolone and calcitriol
Article | Year |
---|---|
Effects of different regimes of corticosteroid treatment on calcium and bone metabolism in rheumatoid arthritis.
Topics: Administration, Oral; Adrenal Cortex Hormones; Adult; Aged; Arthritis, Rheumatoid; Bone and Bones; Calcitriol; Calcium; Female; Humans; Hydroxyproline; Injections, Intravenous; Male; Methylprednisolone; Middle Aged; Parathyroid Hormone; Prednisolone | 1992 |
Bone mineral content after renal transplantation. Placebo-controlled prospective study with 1,25-dihydroxy vitamin D3.
Topics: Adult; Bone and Bones; Bone Diseases; Calcitriol; Densitometry; Forearm; Humans; Kidney Transplantation; Methylprednisolone; Minerals; Placebos; Prospective Studies; Random Allocation; Time Factors | 1984 |
High-dose glucocorticoids in multiple sclerosis patients exert direct effects on the kidney and skeleton.
Topics: Administration, Oral; Adult; Aged; Bone and Bones; Calcitriol; Calcium; Female; Glomerular Filtration Rate; Humans; Injections, Intravenous; Kidney; Male; Methylprednisolone; Middle Aged; Multiple Sclerosis; Osteocalcin; Parathyroid Hormone; Phosphorus; Prednisone | 1994 |
The effects of calcipotriol and methylprednisolone aseponate on bcl-2, p53 and ki-67 expression in psoriasis.
Topics: Administration, Topical; Adult; Apoptosis; bcl-2-Associated X Protein; Calcitriol; Dermatologic Agents; Female; Humans; Ki-67 Antigen; Male; Methylprednisolone; Middle Aged; Psoriasis; Statistics, Nonparametric; Treatment Outcome; Tumor Suppressor Protein p53 | 2006 |
20 other study(ies) available for methylprednisolone and calcitriol
Article | Year |
---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Hologram QSAR model for the prediction of human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Holography; Humans; Models, Biological; Models, Molecular; Molecular Structure; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2007 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Effects of methylprednisolone and uremia on renal and intestinal calbindin-D in the rat.
Topics: Animals; Blood Urea Nitrogen; Calbindin 1; Calbindins; Calcitriol; Calcium; Creatinine; Female; Intestinal Mucosa; Intestines; Kidney; Methylprednisolone; Phosphates; Proteins; Rats; Rats, Wistar; S100 Calcium Binding Protein G; Uremia | 1992 |
Acute changes in calcium and bone metabolism during methylprednisolone pulse therapy in rheumatoid arthritis.
Topics: Adult; Aged; Aged, 80 and over; Alkaline Phosphatase; Arthritis, Rheumatoid; Bone and Bones; Calcitriol; Calcium; Chronic Disease; Creatinine; Female; Humans; Hydroxyproline; Male; Methylprednisolone; Middle Aged; Parathyroid Hormone; Time Factors | 1988 |
Effect of methyl prednisolone on 1,25 dihydroxyvitamin D in rabbits.
Topics: Animals; Calcitriol; Methylprednisolone; Rabbits; Time Factors | 1986 |
Bone metabolism during methylprednisolone pulse therapy in rheumatoid arthritis.
Topics: Adult; Aged; Arthritis, Rheumatoid; Bone and Bones; Calcitriol; Calcium; Female; Humans; Hydroxyproline; Male; Methylprednisolone; Middle Aged; Parathyroid Hormone | 1986 |
Differential effects of glucocorticoids on human osteoblastic cell metabolism in vitro.
Topics: Adult; Alkaline Phosphatase; Anti-Inflammatory Agents, Non-Steroidal; Biopsy; Calcitriol; Cells, Cultured; Dexamethasone; DNA; Dose-Response Relationship, Drug; Glucocorticoids; Humans; Kinetics; Methylprednisolone; Osteoblasts; Osteocalcin; Prednisolone; Pregnenediones; Procollagen; Time Factors | 1995 |
Factors involved in the loss of bone mineral density after renal transplantation.
Topics: Adult; Aged; Aluminum; Bone Density; Calcitriol; Calcium; Chi-Square Distribution; Creatinine; Cyclosporine; Female; Follow-Up Studies; Humans; Hyperparathyroidism; Immunosuppression Therapy; Kidney Transplantation; Male; Methylprednisolone; Middle Aged; Phosphates; Prednisone; Reference Values; Regression Analysis; Time Factors | 1995 |
Triiodothyronine blocks potentiation of HL60 monocyte differentiation by anti-inflammatory agents and by steroids and induces apoptosis of all-trans retinoic acid "primed" cells.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Apoptosis; Calcitriol; Cell Differentiation; Culture Media; Culture Media, Serum-Free; Drug Interactions; Drug Synergism; HL-60 Cells; Humans; Indomethacin; Methylprednisolone; Models, Biological; Tretinoin; Triiodothyronine | 1997 |
New insights on the pathogenesis of hypercalcemia in primary hyperparathyroidism.
Topics: Bone Resorption; Calcitriol; Calcium; Cyclic AMP; Female; Humans; Hypercalcemia; Hyperparathyroidism; Intestinal Mucosa; Kidney Tubules; Methylprednisolone; Middle Aged; Myasthenia Gravis; Parathyroid Hormone | 2000 |
Persistently increased bone turnover and low bone density in long-term survivors to kidney transplantation.
Topics: Adult; Aged; Biomarkers; Bone and Bones; Bone Density; Calcitriol; Creatinine; Cross-Sectional Studies; Cyclosporine; Dose-Response Relationship, Drug; Female; Humans; Immunosuppressive Agents; Kidney; Kidney Failure, Chronic; Kidney Transplantation; Male; Methylprednisolone; Middle Aged; Minerals; Osteocalcin; Parathyroid Hormone; Prevalence; Sex Factors; Statistics as Topic; Survivors; Time Factors | 2001 |
A pediatric case of nephrogenic fibrosing dermopathy: improvement after combination therapy.
Topics: Administration, Topical; Adolescent; Anti-Inflammatory Agents; Bandages; Calcitriol; Dermatologic Agents; Drug Therapy, Combination; Edema; Fibrosis; Humans; Kidney Failure, Chronic; Kidney Transplantation; Male; Methotrexate; Methylprednisolone; Peritoneal Dialysis; Skin Diseases; Treatment Outcome; Triamcinolone | 2006 |
Preventive effects of risedronate and calcitriol on cancellous osteopenia in rats treated with high-dose glucocorticoid.
Topics: Animals; Bone and Bones; Bone Density Conservation Agents; Bone Diseases, Metabolic; Bone Resorption; Calcitriol; Etidronic Acid; Female; Glucocorticoids; Methylprednisolone; Osteogenesis; Random Allocation; Rats; Rats, Sprague-Dawley; Risedronic Acid | 2006 |
An autoregressive linear mixed effects model for the analysis of longitudinal data which show profiles approaching asymptotes.
Topics: Azathioprine; Calcitriol; Computer Simulation; Drug Therapy, Combination; Humans; Hyperparathyroidism; Immunosuppressive Agents; Linear Models; Longitudinal Studies; Methylprednisolone; Multiple Sclerosis; Parathyroid Hormone; Randomized Controlled Trials as Topic; Receptors, Fc | 2007 |
Hypercalcaemia due to isolated elevation of 1,25-dihydroxyvitamin D in patients with Crohn's disease.
Topics: Abdominal Pain; Aged; Anti-Inflammatory Agents; Crohn Disease; Diagnosis, Differential; Female; Humans; Hypercalcemia; Methylprednisolone; Nausea; Vitamin D; Vomiting | 2019 |
Juvenile-onset multifocal osteonecrosis in systemic lupus erythematosus: A case report.
Topics: Adolescent; Bone Density Conservation Agents; Calcitriol; Cyclophosphamide; Dipyridamole; Female; Humans; Immunosuppressive Agents; Lupus Erythematosus, Systemic; Methylprednisolone; Osteonecrosis; Platelet Aggregation Inhibitors | 2021 |
Methylprednisolone stimulated gene expression (GILZ, MCL-1) and basal cortisol levels in multiple sclerosis patients in relapse are associated with clinical response.
Topics: Administration, Intravenous; Adult; Anti-Inflammatory Agents; Calcitriol; Disability Evaluation; Female; Gene Expression; Humans; Hydrocortisone; Leucine Zippers; Male; Methylprednisolone; Middle Aged; Multiple Sclerosis; Multiple Sclerosis, Relapsing-Remitting; Myeloid Cell Leukemia Sequence 1 Protein; Proto-Oncogene Proteins c-bcl-2; Recurrence | 2021 |
The influence of calcitriol and methylprednisolone on podocytes function in minimal change disease in vitro model.
Topics: Calcitriol; Cholecalciferol; Humans; Lipopolysaccharides; Methylprednisolone; Nephrosis, Lipoid; Podocytes | 2023 |